“Ending Epidemics by 2030: The Global Fund’s Strategy and Partnership with Japan”
Seminar with Dr. Mark Dybul, Executive Director of the Global Fund
October 25, 2016 | National Center for Global Health and Medicine, Tokyo
In conjunction with a visit to Japan by Dr. Mark Dybul, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund), we are pleased to announce that a public seminar will be held on the Global Fund’s strategy to achieve the internationally agreed upon goal of ending the three epidemics by 2030, and on the role of partnership with Japan in that process. In addition to Dr. Dybul, the event will feature a panel of experts who will explore concrete examples of Japan’s best practices in fighting HIV/AIDS, tuberculosis, and malaria, as well as in investing in health systems strengthening to achieve UHC; Japan’s comparative advantages in contributing to ending epidemics based on its own experience and successes; and ways to reinforce partnership between the Global Fund and Japan.
October 25, 2016
National Center for Global Health and Medicine, Research Building, 5F, Large Conference Hall
1-21-1 Toyama, Shinjuku, Tokyo 162-8655
The Global Fund; National Center for Global Health and Medicine; Japan Center for International Exchange (JCIE); Friends of the Global Fund, Japan (FGFJ)
Researchers, practitioners, and other representatives from government agencies, international organizations, NGOs, and businesses in the global health field
Satoko Itoh, Managing Director and Chief Program Officer, Japan Center for International Exchange (JCIE); Assistant Director, Friends of the Global Fund, Japan (FGFJ) [MC]
Masato Kasuga, President, National Center for Global Health and Medicine (NCGM)
Mark Dybul, Executive Director, Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund)
Osamu Kunii, Head, Strategy, Investment & Impact Division, The Global Fund
Mark Dybul, Executive Director, The Global Fund
Ikuo Takizawa, Deputy Director General, and Group Director for Health 1, Human Development Department, Japan International Cooperation Agency (JICA)
Nobukatsu Ishikawa, Director, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (JATA)
Ikuma Nozaki, Bureau of International Health Cooperation, NCGM; Advisor for Infectious Disease Control and Laboratory Service in Myanmar
Reiko Hayashi, Director, Department of International Research and Cooperation, National Institute of Population and Social Security Research
Hiroki Nakatani, Professor, Global Initiatives, Keio University
Akio Okawara, President & CEO, JCIE; Director, FGFJ
About Mark Dybul
Mark Dybul has worked on HIV and public health for more than 25 years as a clinician, scientist, teacher, and administrator. After graduating from Georgetown Medical School in Washington DC, Dr. Dybul joined the National Institute of Allergy and Infectious Diseases, where he conducted basic and clinical studies on HIV virology, immunology and treatment optimization, including the first randomized, controlled trial with combination antiretroviral therapy in Africa.
Dr. Dybul became a founding architect and driving force in the formation of the President’s Emergency Plan for AIDS Relief, better known as PEPFAR. After serving as chief medical officer and as assistant, deputy, and acting director, he was appointed as its leader in 2006, becoming US Global AIDS Coordinator, with the rank of ambassador at the level of Assistant Secretary of State. He served until early 2009.
Before coming to the Global Fund, Dr. Dybul was co-director of the Global Health Law Program at the O’Neill Institute for National and Global Health Law at Georgetown University, where he was also a distinguished scholar. Dr. Dybul has written extensively in scientific and policy literature and has received several honorary degrees and awards.